Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00447941
Status:
COMPLETED
Last Update Posted:
2009-08-07
First Post:
2007-03-13
Brief Title:
Safety PK and PD Study in Healthy Male Japanese Subjects
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
Randomized Double-blind Placebo-controlled Ascending Multiple Dose Study of the Safety Pharmacokinetics and Pharmacodynamics of Sca-136 Administered Orally to Healthy Male Japanese Subjects
Status:
COMPLETED
Status Verified Date:
2009-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study assessing pharmacokinetics pharmacodynamics safety and tolerability of oral doses of SCA-136 in healthy male Japanese subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None